Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersRheumatology Physician in Marion, OH
NPI: 1417964966Primary Practice Location
RIVERSIDE METHODIST HOSPITAL
3535 Olentangy River Rd, Columbus, OH
Primary Employer
Marion Area Physicians LLC
ohiohealth.com
HQ Phone
Get M.D. Madhu's Phone NumberMobile
Get M.D. Madhu's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 220 | 434 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 106 | 154 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 61 | 61 |
| 4 | J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 33 | 208 |
| 5 | 99203New patient outpatient visit, total time 30-44 minutes | 30 | 30 |
Authors: Huang, Wei, Bansode, Rishipal R, Xie, Yan, Rowland, Leslie, Mehta, Madhu, Davidson, Nicholas O, Mehta, Kamal D
Journal: J Biol Chem
Publication Date: 2011-05-05
Protein kinase Cβ deficiency attenuates obesity syndrome of ob/ob mice by promoting white adipose tissue remodeling.
Authors: Wei Huang, Rishipal Bansode, Naresh Bal, Madhu Mehta, Kamal Mehta
Publication Date: 2012-01-03
Protein kinase Cβ is required for lupus development in Sle mice.
Authors: David Oleksyn, Mary Pulvino, Jiyong Zhao, Ravi Misra, Aram Vosoughi, Scott Jenks, Christopher Tipton, Frances Lund, George Schwartz, Bruce Goldman, Chandra Mohan, Kamal Mehta, Madhu Mehta, Michael Leitgets, Ignacio Sanz, Luojing Chen
Publication Date: 2012-06-13
Lead Sponsor: Eli Lilly and Company
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: TNF Inhibitor, DRUG: Baricitinib
